▲ Peaking
Business
Seniors in Medicare are about to get landmark obesity drug coverage
Medicare is set to provide coverage for GLP-1 obesity medications starting July 1, reducing costs to $50 a month for qualifying seniors.
3 trends tracked about this subject — the full history, oldest to newest below.
Medicare is set to provide coverage for GLP-1 obesity medications starting July 1, reducing costs to $50 a month for qualifying seniors.
Eli Lilly shares surge following CHMP's recommendation for Jaypirca's EU approval and expanded Medicare access for GLP-1 drugs.
Eli Lilly's CEO outlines the transformative potential of GLP-1s as new oral weight-loss medications enter development.